LABS logo

MediPharm Labs Corp. Stock Price

TSX:LABS Community·CA$38.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

LABS Share Price Performance

CA$0.09
0.00 (5.88%)
CA$0.09
0.00 (5.88%)
Price CA$0.09

LABS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
1 Reward

MediPharm Labs Corp. Key Details

CA$45.1m

Revenue

CA$31.3m

Cost of Revenue

CA$13.9m

Gross Profit

CA$22.1m

Other Expenses

-CA$8.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.019
30.72%
-18.32%
0.4%
View Full Analysis

About LABS

Founded
2015
Employees
127
CEO
Greg Hunter
WebsiteView website
www.medipharmlabs.com

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Recent LABS News & Updates

Recent updates

No updates